On February 11, 2020 the World Health Organization announced an official name for the coronavirus disease, COVID-19.

2019 Novel Coronavirus (COVID-19)

The 2019 Novel Coronavirus (COVID-19) has caused an outbreak of respiratory illness that started in Wuhan City, Hubei Province, China and has now spread throughout the world to many different countries. Coronaviruses are a large family of viruses known to infect both animals and humans...Continue Reading

For more resources about 2019 Novel Coronavirus (COVID-19), visit the following links:

Centres for Disease Control and Prevention (CDC)
World Health Organization (WHO)

We are ready to do our part.

Introducing Norgen's PCR detection solutions for coronavirus based on
the protocol and RT-PCR panel published by the CDC for the detection of COVID-19.


Instructions from CDC | CDC Primer and Probes

These assays are manufactured under Norgen’s ISO 13485:2016 quality system and are for research use only.

2019-nCoV TaqMan RT-PCR Kit
(Cat. TM67100)

  • Detection kit for SARS-CoV-2, which causes COVID-19
    (2019-nCoV)
  • Ready to use format containing everything required for detection
  • Available in 1 format for analysis:

2019-nCoV Primer & Probe Mixes
(Cat. TM67101)

Swab Collection and Total Nucleic Acid Preservation System (Cat. 68800)

Recommended Products and Add-ons

Use Description  
1. Specimens Collection & Preservation Swab Collection and Total Nucleic Acid Preservation System (Cat. 68800) View product page
Saliva RNA Collection and Preservation (Cat. RU53800) View product page
2. RNA Isolation Total RNA Purification Kit (Cat. 17200, 37500) View product page
3. PCR based detection and
add-ons
2019-nCoV Primer & Probe Mixes (Cat. TM67101)* View product page
2019-nCoV RT-PCR Positive Control (Cat. PC67102)** View product page
2X One-Step RT-PCR Master Mix (Cat. 28113) View product page

* This kit includes all 4 assays in individual tubes, which are premixed to the working concentrations recommended by the CDC
** The control plasmid contains the CDC 2019-nCoV markers (N1,N2,N3) and RNase P gene which are compatible with the CDC COVID-19 specific primer/probe sets


Norgen Biotek is not an endorsed supplier of the CDC coronavirus RT-PCR panel or positive controls. Norgen is offering these products based on the sequences that were published by the CDC, and these are being offered to our customers for research use only, not for in vitro diagnostic use

About 2019 Novel Coronavirus (COVID-19)

The 2019 Novel Coronavirus (COVID-19) has caused an outbreak of respiratory illness that started in Wuhan City, Hubei Province, China and has now spread throughout the world to many different countries.

Coronaviruses are a large family of viruses known to infect both animals and humans. The 2019 Novel Coronavirus (COVID-19) is a new strain of coronavirus infecting humans that had not been previously detected before the outbreak in China in December 2019. While the 2019 Novel Coronavirus (COVID-19) is new, many coronaviruses have been known to infect animals and humans for some time. Coronaviruses are known to commonly infect camels, cattle, cats, and bats. In humans, Coronavirus infections can cause various illnesses from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS).

Human infection is more severe when the coronavirus has originated in animals and spread to humans, as is the case with MERS and SARS. The COVID-19 is a betacoronavirus, similar to MERS and SARS, both of which have their origins in bats. The animal source of COVID-19 has not yet been identified, however Chinese officials have linked many of the early cases to a large seafood and live animal market, suggesting that the initial transmission was the result of animal-to-person spread. However, many of the later detected cases did not report any exposure to animal markets, indicating that the virus is now spreading via human-to-human contact.

Symptoms of infection with the COVID-19 can range from milder symptoms such as a runny nose, sore throat, cough, and fever to more severe symptoms including pneumonia or breathing difficulties. In some cases infection with the COVID-19 has resulted in death. As with other respiratory illnesses, older people and individuals with pre-existing medical conditions (such as diabetes or heart disease) are more vulnerable to becoming severely ill with the virus.

The Chinese authorities posted the full genome of the COVID-19 on the NIH sequencing database GenBank. The CDC reported that the first cases of COVID-19 in the US that were sequenced are similar to the sequence published by China, therefore adding further evidence to the fact that there was a single, recent emergence of this virus from an animal source.

Accurate diagnosis of infection with COVID-19 is through the use of real-time RT PCR (rRT-PCR) assays for the in vitro qualitative detection of 2019-Novel Coronavirus (COVID-19) in respiratory specimens and sera. The CDC has published full guidelines on their website for the collection, storage and handling of specimens, nucleic acid extraction, quality control, the rRT-PCT detection assay (including the probes and primers), and interpreting test results https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-detection-instructions.html.

For further information related to the 2019 Novel Coronavirus (COVID-19), please see the following links:

Centres for Disease Control and Prevention (CDC)
World Health Organization (WHO)